mobile header
Dr Kunal Chhattani

Dr Kunal Chhattani american Oncology Hospitals

Dr Kunal Chhattani

Consultant - Hemato-Oncology and Bone Marrow Transplant

Book an Appointment
Share Profile share

Dr. Kunal Chhattani is one of the best Hemato-Oncologist and Bone Marrow Transplant (BMT) physicians in Nagpur with over 6 years of experience in Clinical Hematology. He completed his DrNB in Clinical Hematology from Dr. B. L. Kapur Memorial Institute, New Delhi, and has been actively involved in managing complex hematological disorders and stem cell transplantation cases.

His areas of expertise include acute leukemias, myeloproliferative neoplasms, lymphomas, multiple myeloma, cytopenia evaluation, immune thrombocytopenia, hemoglobinopathies, and complex anemia management. He is experienced in performing hematopoietic stem cell transplants, including autologous, allogenic, haploidentical, and matched unrelated donor (MUD) transplants.

Dr. Kunal is currently associated with American Oncology Institute, Nagpur, as an Associate Consultant. He has previously worked with leading hospitals in Nagpur and also runs a dedicated hematology clinic.

He has contributed to academic research with a publication focused on regulatory T cells and their role in graft-versus-host disease following allogeneic stem cell transplantation.

He is committed to delivering evidence-based, patient-centric care in the field of hemato-oncology and advanced transplant medicine.

  • MBBS - Indira Gandhi Government Medical College & Hospital (IGGMC), Nagpur, 2005 - 2010
  • MD - Pathology, Government Medical College, Nagpur, 2013 - 2016
  • DrNB - Clinical Hematology, Dr BL Kapur Memorial Institute, New Delhi, 2017 - 2020
  • Associate Consultant - Hematology and BMT, American Oncology Institute, Nagpur, 2020 - 2021
  • Consultant - Hematology and BMT, Care Hospital, Nagpur, 2023 - 2026
  • Owner, Chhattani Hematology Clinic, Ramdaspeth, Nagpur, 2021 - Present
  • Consultant - Hematology and BMT, Meditrina Institute of Medical Sciences, Nagpur, 2023 - 2025
  • Bone Marrow Transplantation
  • Acute Leukemia Management
  • Myeloproliferative Neoplasm Management
  • Lymphoma Management
  • Multiple Myeloma Treatment
  • Hematopoietic Stem Cell Transplantation (Autologous, Allogenic, Haploidentical, MUD)
  • Cytopenia Evaluation and Management
  • Immune Thrombocytopenia Management
  • Hemoglobinopathy Management
  • Complex Anemia Evaluation and Management
  • Regulatory T cells in the graft and the risk of Acute Graft Versus Host disease after Allogenic Stem cell transplant.
  • MMC - 2022/03/0589
  • English
  • Hindi